Pro-Dex (PDEX) - EV/EBITDA Multiple

Pro-Dex Inc. - graphic logo of issuer PDEX

The market trend for Pro-Dex, Inc. (PDEX) illustrated on the price chart is based on deep partnerships with key brands for the co-creation of equipment, and the current EV/EBITDA ratio stands at 15.60. Pro-Dex, Inc. (PDEX) produces rotary systems and instruments for dentistry and surgery, mitigating risks through global sales. The business relies on demand in orthopedics, adherence to strict quality standards, and long-term OEM agreements.

PDEX Pro-Dex Corp: Enterprise Value to Operating Income Before Depreciation in the range 11/23/2025 - 11/10/2026
Manufactured products of Pro-Dex

Investors are assessing the resilience of Pro-Dex, Inc. (PDEX) through the enterprise value to EBITDA ratio, which allows for the determination of the real value of assets while accounting for debt load and taxes. By analyzing the EV/EBITDA metric of Pro-Dex, Inc. (PDEX) across a financial timeline, one can understand how the scaling of robotic surgery and new OEM contracts impact the efficiency of invested capital, preventing an overpayment for the asset.

Competitors of Pro-Dex, Inc.

Intuitive Surgical Inc - Enterprise Value to EBITDA Ratio|Business Value to Operating Income Before Depreciation DHR|Becton Dickinson & Co - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio steris.com STE|West Pharmaceutical Services, Inc. (WST) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BAX|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Masimo Personal Health|Stevanato Group Corp (STVN) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio TFX (Teleflex Incorporated)|Enterprise Value to Operating Income Before Depreciation Ratio MMSI|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envista NVST|Business Value to Operating Income Before Depreciation ICUI|XRAY: Enterprise Value to EBITDA Ratio|LMAT - EV/EBITDA Multiple|AtriCure, Inc. (ATRC) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio staar.com|NAGE (ChromaDex Corp.) - EV/EBITDA Multiple|Company Value to EBITDA ZimVie Inc ZIMV|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AngioDynamics Corp (ANGO)|Cerus Inc - Enterprise Value to Operating Income Before Depreciation|Alpha Teknova, Inc. - Enterprise Value to EBITDA Ratio|Enterprise Value to Operating Income Before Depreciation Ratio MGRM (monogramorthopedics.com)|STSS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Total Company Value to Operating Income Before Depreciation Ratio InfuSystem Holdings INFU|Utah Medical (UTMD) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio KRMD (KORU Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nyxoah S.A.|MBOT: Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zentek (ZTEK)|ELUT - Company Value to EBITDA|Milestone Scientific Corp - Enterprise Value to EBITDA Ratio|Enterprise Value to EBITDA Multiple NEXGEL Inc|Retractable Tech - EV/EBITDA Multiple|HBIO (Harvard Bioscience Inc.) - Enterprise Value to Operating Income Before Depreciation|FEMY: EV/EBITDA Multiple|Company Value to EBITDA Meihua Medical Technologies Co., Ltd. (MHUA)|Enterprise Value to EBITDA Ratio POAI|Enterprise Value to Operating Income Before Depreciation CJMB (Callan JMB Corp)|Enterprise Value to EBITDA Ratio ATRI (Atrion Corporation)|NURO (neurometrix.com) - Business Value to Operating Income Before Depreciation